Form 10-K for the Year Ended December 31, 2020
We note your disclosure under this heading that you adjust for non-recurring expenses that management does not consider in assessing ongoing performance. We further note that your reconciliation of EBITDA and Adjusted EBITDA to net income on page 31 includes adjustments for non-recurring payroll expense and severance and related costs in 2020.Rest of the question
Please tell us how you determined payroll expense qualifies to be described as nonrecurring and how each of these adjustments does not represent normal, recurring cash expenses necessary to operate your business. Refer to Item 10(e)(1)(ii)(B) of Regulation S-K and Questions 100.01 and 102.03 of the Non-GAAP Financial Measures Compliance and Disclosure Interpretations for guidance.
Non-recurring Payroll ExpenseRead in the reply
Non-recurring payroll expense of $2.398 million recorded in 2020 was related to a one-time payment to the Company sponsored 401(k) plan (the “Plan”) as a result of a submission under the IRS’ Voluntary Correction Program (“VCP”).
The Company has maintained the Plan since 2013. The Company has never previously submitted a VCP or made related payments.Rest of the answer
Further, effective January 1,
2020, the Company amended the Plan to address the errors subject to the VCP submission so that they would not reoccur in the future.
The Company considered the guidance of Item 10(e)(1)(ii)(B) of Regulation S-K, as well as Questions 100.01 and 102.03 of the Non-GAAP Financial Measures Compliance and Disclosure Interpretations, and determined, based on the information summarized above, that the payroll expense for the VCP related payment was properly described as “non-recurring” as the Company concluded it was not reasonably likely that a similar charge would recur within two years and there was no similar charge that had occurred in the prior two years. This adjustment does not represent the normal, recurring cash expenses necessary to operate our business as the Company has never submitted or made payments under the VCP program before, and has amended the Plan so that the errors subject to the VCP submission will not recur in the future.
Severance and Related Costs
Severance and related costs of $10.166 million recorded in 2020 were primarily related to the reduction in our workforce in April 2020 and the commencement of furlough schedules for remaining employees in May 2020 during which the Company continued to pay health insurance and other benefits.
Following the onset of the COVID-19, the Company regrettably conducted a Company-wide reduction in force whereby its personnel count decreased by approximately 50%. At the same time, the Company also implemented a temporary furlough plan which spanned portions of May – August 2020. The Company provided multiple weeks of severance pay in conjunction with the reduction in force. During furlough periods, the Company paid the employee and employer portions of health and related benefit costs on behalf of the furloughed employees.
The Company considered the guidance of Item 10(e)(1)(ii)(B) of Regulation S-K, as well as Questions 100.01 and 102.03 of the Non-GAAP Financial Measures Compliance and Disclosure Interpretations, and determined, based on the information summarized above, the severance and related costs adjustment did not represent the normal, recurring cash expenses necessary to operate our business as i) the Company has never before conducted a Company-wide reduction in force and generally operates to avoid “seasonal” or recurring layoffs despite the cyclical nature of our industry, and ii) severance pay and the cost of health and related benefits for furloughed employees not working for customers are neither normal recurring cash expenses nor necessary costs to operate our business (active employees are necessary;
not furloughed employees). Both of these costs were voluntarily incurred and resulted from an unprecedented decline in commercial activity in the second quarter of 2020 due to the onset of a global pandemic.
First report after the company's reply of Jul 21, 2021: 10-Q filed Jul 30, 2021 ↗, against the 10-Q filed Apr 30, 2021 ↗.
Tickdelta does not hold the text of both reports, so they are not compared here.
We note your response to prior comment 1 indicates that severance and related costs of $10.166 million were primarily related to the reduction in workforce in April 2020 and temporarily furloughed employees spanning portions of May to August 2020.Rest of the question
Please provide the following: • Quantify the amount recorded in your non-GAAP adjustment for each of the components, including reduction in workforce, payment of salaries to furloughed employees and payment of health insurance and other benefits for these employees. • Clarify if your reduction in workforce resulted in the permanent termination of employees. If employees were permanently terminated, please quantify the amount of expense included in the adjustment related to these employees. • Your response indicates severance pay and the cost of health and related benefits for furloughed employees not working for customers are neither normal recurring cash expenses nor necessary costs to operate your business. When considering the compensation paid to employees temporarily furloughed, please explain further why you believe employee compensation paid during the pandemic for employees that returned to work is considered incremental to your normal operations. In closing, we remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
The dollar amount for each component is as follows:Read in the reply
i.
Reduction in workforce
$7.502 million ii.
Salaries to furloughed employees
$0.0 iii.
Health insurance to furloughed employees
$2.664 million
$10.166 million
Clarify if your reduction in workforce resulted in the permanent termination of employees. If employees were permanently terminated, please quantify the amount of expense included in the adjustment related to these employees
Response:
The reduction in workforce did result in the permanent termination of employees.Rest of the answer
The amount of expense included in the adjustment related to these employees was $7.5 million, as shown in the summary above.
Your response indicates severance pay and the cost of health and related benefits for furloughed employees not working for customers are neither normal recurring cash expenses nor necessary costs to operate your business. When considering the compensation paid to employees temporarily furloughed, please explain further why you believe employee compensation paid during the pandemic for employees that returned to work is considered incremental to your normal operations.
Response:
No wage or salary compensation was paid to furloughed employees. The only benefit provided was that the Company, on a voluntary basis, continued to provide health insurance benefits to the furloughed employees. We believe this cost is incremental to our normal operations because we do not normally incur health care costs for employees that are not actively providing services for us.
First report after the company's reply of Aug 30, 2021: 10-Q filed Oct 28, 2021 ↗, against the 10-Q filed Apr 30, 2021 ↗.
Tickdelta does not hold the text of both reports, so they are not compared here.
Also in this review: closing letter, 2021-09-01